Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
THERAPEUTIC DRUG FOR NEURODEGENERATIVE DISEASE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/154195
Kind Code:
A1
Abstract:
The present invention relates to a novel therapeutic drug for a neurodegenerative disease and an application thereof. Provided is a novel compound of formula (I). The compound can effectively facilitate the proliferation of neural stem cells in both in vitro and in vivo experiments and can be used as a treatment approach for facilitating neuroregeneration to fight against cognitive decline associated with aging or a neurodegenerative disease.

Inventors:
PEI GANG (CN)
YU BIAO (CN)
HUANG SHICHAO (CN)
CAO XIN (CN)
SHI FUCHUN (CN)
ZHOU YUE (CN)
AN YUQIAN (CN)
LU JING (CN)
Application Number:
CN2019/073773
Publication Date:
August 15, 2019
Filing Date:
January 29, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI DONGXI ZHIHUI BIOLOGICAL MEDICINE CO LTD (CN)
International Classes:
C07H13/02; A61K31/165; A61K31/216; A61P25/00; A61P25/16; A61P25/24; A61P25/28; C07H1/00; C07H15/20
Foreign References:
CN104958287A2015-10-07
CN105906672A2016-08-31
Other References:
GROND, S. ET AL.: "Novel alpha-L-Rhamnopyranosides from a Single Strain of Streptomyces by Supplement-Induced Biosynthetic Steps", EUR. J. ORG. CHEM., vol. 19, 31 December 2002 (2002-12-31), pages 3237 - 3242
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: